Cytosorbents
CTSO
#9825
Rank
$45.85 M
Marketcap
$0.73
Share price
-1.20%
Change (1 day)
-21.49%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -$11.45 Million USD

According to Cytosorbents's latest financial reports the company's current earnings are $36.1 Million USD. In 2024 the company made an earning of -$22.3 Million USD, an increase over its 2023 earnings that were of -$29.33 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$11.45 Million-48.68%
2024 -$22.3 Million-23.97%
2023 -$29.33 Million-13.52%
2022 -$33.91 Million34.04%
2021 -$25.3 Million182.17%
2020 -$8.97 Million-55.97%
2019 -$20.36 Million14.17%
2018 -$17.84 Million95.14%
2017 -$9.14 Million-22.32%
2016 -$11.77 Million39.1%
2015 -$8.46 Million-12.89%
2014 -$9.71 Million89%
2013 -$5.14 Million26.65%
2012 -$4.06 Million-26.02%
2011 -$5.49 Million-288.45%
2010 $2.9 M-4.17%
2009 $3.03 M-287.19%
2008 -$1.63 Million-47.12%
2007 -$3.07 Million41.78%
2006 -$2.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
$55.5 M-585.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
$0.79 B-7,057.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
$3.27 B-28,683.67%๐Ÿ‡บ๐Ÿ‡ธ USA